Cal-Maine Foods
Producer of conventional and specialty eggs, egg products, and prepared breakfast foods.
Something off on this page? Send us feedback.
Profile
Produces and distributes conventional and specialty shell eggs nationwide while adding egg products and prepared breakfast foods. Revenue comes mainly from U.S. retail and foodservice customers, with results shaped by egg and feed prices, flock health, and specialty-egg demand.
Produces, grades, packages, markets, and distributes conventional and specialty shell eggs to retail and foodservice customers nationwide. Specialty offerings span cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs.
Extends beyond shell eggs through egg products, hard-cooked eggs, and prepared foods such as egg patties, omelets, scrambled egg formats, pancakes, waffles, and wraps. Operations are now managed through three reportable segments: Conventional Shell Eggs, Specialty Shell Eggs, and Prepared Foods.
Runs a vertically integrated production and distribution network positioned near customers and has broadened the portfolio through acquisitions and capacity investments. Revenue is primarily U.S.-based, while results remain tied to shell-egg and feed-grain prices, flock health and biosecurity, and demand for cage-free and other specialty eggs.
Company facts
Categories
Key statistics
Year to date +2.3% · Average volume (30d) 953.7K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Jul 13, 2026 | Wells Fargo | Target | $100 | ||
| May 26, 2026 | RBC Capital | Target | $100 | ||
| Jan 8, 2026 | Stephens | Target | $95 | $85 | |
| Jan 8, 2026 | BMO Capital | Reiterate | Market Perform | $85 | |
| Dec 30, 2025 | Stephens | Target | $97 | $95 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026Q4 FY26 | $0.08 | −$0.76 | −1,021.2% | $563.8M | $552.6M | −2.0% | +0.32% |
| Apr 1, 2026Q3 FY26 | $0.70 | $1.06 | +52.3% | $642.5M | $667.0M | +3.8% | −6.31% |
| Jan 7, 2026Q2 FY26 | $1.95 | $2.13 | +9.2% | $796.6M | $769.5M | −3.4% | −3.02% |
| Oct 1, 2025Q1 FY26 | $5.01 | $4.12 | −17.8% | $960.3M | $922.6M | −3.9% | −0.41% |
Financial highlights
| 12 quarters | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.10B | $922.6M | $769.5M | $667.0M | $552.6M | |
| Gross profit | $716.1M | $531.5M | $311.3M | $207.4M | $119.3M | $34.1M | |
| Operating income | $635.7M | $435.9M | $249.3M | $124.5M | $36.0M | −$59.5M | |
| Net income | $508.5M | $342.5M | $199.3M | $102.8M | $50.5M | −$35.9M | |
| Diluted EPS | $10.38 | $7.04 | $4.12 | $2.13 | $1.06 | −$0.76 | |
| Gross margin | 50.5% | 48.2% | 33.7% | 27.0% | 17.9% | 6.2% | |
| Operating margin | 44.8% | 39.5% | 27.0% | 16.2% | 5.4% | -10.8% |
Fiscal years (4-quarter sums)FY22 $1.78B · FY23 $3.15B · FY24 $2.33B · FY25 $4.26B · FY26 $2.91B
Revenue by product · FY26
Balance sheet, May 30, 2026Cash & short-term investments $924.1M · Total debt $0 · Total assets $3.11B · Shareholders' equity $2.63B
Dividends
Last cut to $0.357 from $0.723 in Apr 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Apr 29, 2026 | Apr 29 | May 14 | $0.357 | cut from $0.723 |
| Jan 28, 2026 | Jan 28 | Feb 12 | $0.723 | cut from $1.378 |
| Oct 29, 2025 | Oct 29 | Nov 13 | $1.378 | cut from $2.354 |
| Aug 4, 2025 | Aug 4 | Aug 19 | $2.354 | cut from $3.495 |
| Apr 30, 2025 | Apr 30 | May 15 | $3.495 | raised from $1.489 |
| Jan 29, 2025 | Jan 29 | Feb 13 | $1.489 | raised from $1.019 |
| Oct 30, 2024 | Oct 30 | Nov 14 | $1.019 | raised from $0.77 |
| Aug 5, 2024 | Aug 5 | Aug 20 | $0.77 | cut from $0.997 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 46.92M · Float 42.20M · 89.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.92M | 14.74% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 2.84M | 6.06% | 13F | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 2.74M | 5.85% | 13F | Aug 11, 2026 |
| American Century Companies Inc | 2.52M | 5.37% | 13F | Aug 12, 2026 |
| Stowers Institute for Medical Research | 2.52M | 5.30% | 13G | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Oct 2, 2025 | Keira L. Lombardo | officer: Chief Strategy Officer | +2,800 | $92.36 |
Peers
- Post
Major public rival in egg products and foodservice eggs
- Vital Farms
Premium specialty eggs and value-added egg products
- Tyson Foods
Adjacent prepared-foods rival in breakfast and foodservice
- Conagra Brands
Adjacent competitor in frozen and foodservice prepared foods
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Cal-Maine Foods | $80.21 | −0.07% | $3.76B | 12.2 | 51.0 | 1.3 | −49.9% |
| Post | $84.16 | −1.37% | $3.87B | 15.7 | 12.1 | 0.5 | −1.8% |
| Vital Farms | $10.82 | +0.23% | $462.3M | — | 7,358.6 | 0.6 | −10.1% |
| Tyson Foods | $55.46 | +0.09% | $19.64B | 34.0 | 12.6 | 0.4 | −0.1% |
| Conagra Brands | $16.05 | −0.22% | $7.70B | — | 10.7 | 0.7 | +3.6% |
| Median | 24.8 | 12.4 | 0.5 | −1.0% |